Results 1 -
10
of
31
for
Bortezomib
- Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle ... begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic ...
- Panobinostat is used in combination with bortezomib (Velcade) and dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated ...
- ... 4 other treatments. Selinexor is also used with bortezomib and dexamethasone to treat multiple myeloma in patients ... of each week. For use in combination with bortezomib and dexamethasone for the treatment of multiple myeloma, ...
- ... the immune system) who have been treated with bortezomib (Velcade) and at least one other medication. Lenalidomide ...
- ... lenalidomide (Revlimid) and a proteasome inhibitor such as bortezomib (Velcade) or carfilzomib (Kyprolis). It is also used ...
- ... lenalidomide (Revlimid) and a proteasome inhibitor such as bortezomib (Velcade) or carfilzomib (Kyprolis). It is also used ...
- Multiple Myeloma: Patient Handbook (International Myeloma Foundation) - PDFMultiple Myeloma/Start Here ... Multiple Myeloma ... International Myeloma Foundation ... PDF
- Stages of Plasma Cell Neoplasms (Including Multiple Myeloma) (National Cancer Institute)Multiple Myeloma/Diagnosis and Tests ... Multiple Myeloma ... National Cancer Institute ... From the National Institutes of Health ... Treatment of plasma cell neoplasms ( ...
- General Information about Plasma Cell Neoplasms (Including Multiple Myeloma) (National Cancer Institute)Amyloidosis/Related Issues ... Amyloidosis ... Multiple Myeloma/Start Here ... Multiple Myeloma ... National Cancer Institute ... From the National Institutes of Health ... Treatment ...
- Treatment Option Overview (National Cancer Institute)Multiple Myeloma/Treatments and Therapies ... Multiple Myeloma ... National Cancer Institute ... From the National Institutes of Health ... Treatment of plasma cell neoplasms ( ...